A phase I study of CPT-11 plus chronomodulated (chrono) 5-Fluorouracil (5-FU) and L-folinic acid (FA) in advanced colorectal cancer (ACC) patients

被引：0
|
作者：
Garufi, C
Tampellini, M
D'Attino, RM
Nistico, C
Aschelter, AM
Pugliese, P
Caterino, M
Giunta, S
Faranda, A
Tropea, F
Comis, S
Dogliotti, L
Terzoli, E
机构：
[1] Ist Regina Elena, I-00161 Rome, Italy
[2] Univ Turin, Turin, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178P
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Vanni, B
    Aschelter, AM
    Zappalà, AR
    Bria, E
    Nisticò, C
    Sperduti, I
    Cognetti, F
    Terzoli, E
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (05) : 608 - 616
  • [2] Folinic acid (FA) and 5-fluorouracil (FU) alone or with irinotecan (CPT-11) for advanced colorectal cancer (ACC): Preliminary results of a randomized phase II trial
    Maiello, E
    Giuliani, F
    Gebbia, V
    Cigolari, S
    Fortunato, S
    Paoletti, G
    Borsellino, N
    Lopez, M
    Gebbia, N
    Colucci, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S71 - S71
  • [3] CPT-11/5-fluorouracil(5-FU)/leucchorin (FA)/oxaliplatin (L-OHP) (CPT-11-FFL) plus cetuximab (Cmab) in unselectecl advanced colorectal cancer (ACC) patients.
    Garufi, C.
    Torsello, A.
    Campanella, C.
    Ettorre, G. M.
    Vennarecci, G.
    Melucci, E.
    Zeuli, M.
    Sperduti, I.
    Gelibter, A.
    Cognetti, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Addition of oxaliplatin (L-OHP(R)) to chronomodulated (CM) 5-fluorouracil (5-FU) and folinic acid (FA) for reversal of acquired chemoresistance in patients with advanced colorectal cancer (ACC)
    Garufi, C
    Bensmaine, MA
    Brienza, S
    Misset, JL
    Aschelter, A
    Pace, R
    BertheaultCvitkovic, F
    Terzoli, E
    Levi, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 124 - 124
  • [5] Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
    Harba, A
    Peinert, S
    Grothe, W
    Jordan, K
    Kegel, T
    Mueller, LP
    Behrens, R
    Grothey, A
    Arnold, D
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 300S - 300S
  • [6] Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU):: A phase II study
    Antón, A
    Aranda, E
    Carrato, A
    Marcuello, E
    Massutti, B
    Cervantes, A
    Abad, A
    Sastre, J
    Fenández-Martos, C
    Gallén, M
    Díaz-Rubio, E
    Huarte, L
    Balcells, M
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2003, 25 (08): : 639 - 643
  • [7] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients
    Edmondo Terzoli
    Carlo Garufi
    Albina Rita Zappalà
    Barbara Vanni
    Patrizia Pugliese
    Giancarlo Antonini Cappellini
    Anna Maria Aschelter
    Maria Perrone
    Diana Giannarelli
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 445 - 452
  • [8] High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5-16) in advanced colorectal cancer patients
    Terzoli, E
    Garufi, C
    Zappalà, AR
    Vanni, B
    Pugliese, P
    Cappellini, GA
    Aschelter, AM
    Perrone, M
    Giannarelli, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (08) : 445 - 452
  • [9] FOLINIC ACID (FA) AND 5-FLUOROURACIL (5-FU) - PHASE-I-II STUDY
    CUNNINGHAM, JR
    BUKOWSKI, RM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 221 - 221
  • [10] The effects of chronomodulated therapy with 5-fluorouracil (5-Fu) and folinic acid (Fa) on the toxicity and quality of life in patients with advanced gastric cancer
    Yalcin, B
    Akbulut, H
    Buyukcelik, A
    Sencan, O
    Demirkazik, A
    Onur, H
    Senler, FC
    Dincol, D
    Icli, F
    BIOLOGICAL RHYTHM RESEARCH, 2004, 35 (4-5) : 259 - 268
12345